Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224)

Clinical trial NCT00928200 · TERMINATED

Trial details

NCT number: NCT00928200
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed Acute Lymphoblastic Leukemia Allergy to PEG e.Coli Asparaginase Allergy to Native e.Coli Asparaginase

Start date: 2009-04-13
Primary completion: 2010-06-04
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.